Oncology & Cancer

Study reveals optimal particle size for anticancer nanomedicines

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy. Understanding the interdependency of physiochemical properties of nanomedicines, ...

Oncology & Cancer

Yeast studies suggest alternative cancer approach

Yeast populations exposed to a sudden environmental shock can be driven to extinction, MIT researchers have shown. Could this principle also apply to human cancer cells? Possibly, argue researchers from MIT, Boston University, ...

Oncology & Cancer

Y-90 provides new, safe treatment for metastatic breast cancer

A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options remain, according to research being ...

Oncology & Cancer

Many women suffer persistent pain after mastectomy

(HealthDay)—Although breast cancer treatments have dramatically improved outcomes for women with the disease, ongoing pain continues to trouble many survivors long after they undergo a mastectomy, a new study finds.

Oncology & Cancer

NEETs are prime suspects in breast cancer proliferation

Two proteins have been identified as prime suspects in the proliferation of breast cancer in a study by an international consortium of researchers from Rice University, the University of North Texas, Denton (UNT); the University ...

Oncology & Cancer

Serum miR-21 putative biomarker for colorectal cancer

(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer ...

page 5 from 9